Navigation Links
Hearing 'messages' embedded in noise could be early sign of schizophrenia
Date:10/24/2007

New Haven, Conn.A tendency to extract messages from meaningless noise could be an early sign of schizophrenia, according to a study by Yale School of Medicine researchers.

The study this month in the British Journal of Psychiatry reported on 43 participants diagnosed with prodromal symptoms meaning they exhibited early warning signs of psychosis such as social withdrawal, mild perceptual alterations, or misinterpretation of social cues.

Participants in the study were randomly assigned to take the anti-psychotic medication olanzapine or a placebo, and then symptoms and neuropsychological function were assessed for up to two years.

During the babble task, participants listened with headphones to overlapping recordings of six speakers reading neutral texts, which made the words virtually incomprehensible. The participants were asked to repeat any words or phrases that they heard. Only four wordsincrease, children, A-OK, and Republicanwere consistently reproduced.

Eighty percent of the participants who heard phrases of four or more words in length went on to develop a schizophrenia-related illness during times that they were not taking olanzapine, said the lead author, Ralph Hoffman, M.D., associate professor of psychiatry. In contrast, only six percent of those in the study converted to schizophrenia-related illness if the phrases heard were less than three words in length.

A tendency to extract message-like meaning from meaningless sensory information can, over time, produce a matrix of unreality that triggers the initial psychotic phase of schizophrenia-spectrum disorders, Hoffman said.

He said further research is needed because of the small size of this study. However, if these findings are verified, Hoffman added, they could provide an inexpensive tool for identifying those individuals with early warning signs of schizophrenia who would most likely benefit from preventive drug therapy.


'/>"/>

Contact: Jacqueline Weaver
jacqueline.weaver@yale.edu
203-432-8555
Yale University
Source:Eurekalert

Page: 1

Related medicine news :

1. Noise tampers hearing
2. A High-Definition Hearing Aid that thinks for you
3. A new hearing device improves hearing
4. Assessment for hearing aid implants in the process
5. Hearing loss can be detected by simple screening
6. Vitamin E Could Restore Sudden Hearing Loss
7. Hearing loss can happen from regular exposure to carbon monoxide
8. Parents understand better the hearing loss problem in children if counseled
9. Studies On Hearing Loss Discovers New Causes
10. Possibility Of Treatment For Permanent Hearing Loss
11. Hearing Problems Of Middle Age Are Affecting The Younger Generation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2008)...l Sloan-Kettering Cancer Center, New York, have de...of genes for therapeutic purposes, and used this t... Small, noncoding RNA molecules known as miRNAs a... In the study, the miRNA miR-181a was harnessed to...wn as T cells at different stages of their develop...
(Date:12/1/2008)...ene repressors for anticancer therapy , Michel...ing Cancer Center, New York, have developed a new ...herapeutic purposes, and used this to mediate effe...ding RNA molecules known as miRNAs are powerful na... the miRNA miR-181a was harnessed to segregate exp...
(Date:12/1/2008)...igher mortality and lower surgery rates in women v...akage may be related to the complexity of evaluati... findings of a Mayo Clinic study published this mo...al valve prolapse affects approximately 150 millio...ery, preferably valve repair rather than replaceme...
(Date:12/1/2008)... Westaim Corporation today announced it has requis...ST Pharmaceuticals Corp. to consider a return of c...$15 million or US$0.80 per share. Westaim will con... of its 74.5 per cent stake in NUCRYST. Under the ... of Directors has 20 days to call a meeting of sha...
Breaking Medicine News(10 mins):Health News:JCI online early table of contents: Dec. 1, 2008 2Health News:JCI online early table of contents: Dec. 1, 2008 3Health News:JCI online early table of contents: Dec. 1, 2008 4Health News:Women with mitral valve prolapse are treated less aggressively than men and may be at high risk 2Health News:The Westaim Corporation requisitions meeting of shareholders of NUCRYST Pharmaceuticals to return capital to NUCRYST shareholders 2
...chiatrist Alois Alzheimer formally described chara...h ultimately came to bear his name. While internat...nd develop treatments have progressed significantl...lusive goal. A new research tool developed by Sus...
...the risk of dementia according to recent research....e a lower risk of dementia and Alzheimer’s disease...h oil is a key factor that is required for the pro...nervous system. These findings have been published...
...e risk of developing skin cancer is very high in l...one by researchers from Medical University of Graz...rnal. The study found out that marathon runners ha... and moles on their skin .Both liver spots and mol...
...killing abilities of existing cancer drugs? A prec...-AACR symposium on Molecular Targets and Cancer Th...at the answer is “yes.” These findings may lead to...ffering from non-small cell lung cancer (NSCLC), a...
Other Medicine News:Health News:Yeast Model Shows Promise as Alzheimer's Test 2Health News:Common Virus Enhances Cancer-Fighting Ability of Standard Chemotherapy Drugs 2
(Date:12/1/2008)... TargeGen has announced that an ora...ti-center, US-based clinical,trial of TG101348 in...duled at,the 2008 American Society of Hematology ...ion are as follows:, Title: A P... JAK2-Selective Inhibitor, ...
(Date:12/1/2008)... S*BIO Pte Ltd today announced the ..., a potent and orally-active JAK2 inhibitor, in le...th chronic idiopathic myelofibrosis (CIMF). , ... and tolerability of SB1518 in patients with CIMF ...hase 1 part of the study will assess the safety pr...
(Date:12/1/2008)... 1 Roche announced today that a,c... in perceived pain and,discomfort associated with...cose monitoring systems and lancing devices were d...at, overall, the ACCU-CHEK Aviva and ACCU-CHEK Com...e ACCU-CHEK Multiclix, ACCU-CHEK,Softclix and ACC...
(Date:12/1/2008)...ophosphatasia Treated With ENB-0040 at Children,s ... , MONTREAL, Dec. 1 Enobia Phar...n developing novel therapeutics for serious bone d...tient in its clinical program for hypophosphatasia...ment Therapy (ERT) with ENB-0040 for the treatment...
Breaking Medicine Technology:S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 2S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 3Study Shows ACCU-CHEK(R) Blood Glucose Monitoring Systems and Lancing Devices Are Least Painful 2Study Shows ACCU-CHEK(R) Blood Glucose Monitoring Systems and Lancing Devices Are Least Painful 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5Maine Community Pharmacy Owner Thanks Sen Snowe for Supporting Inclusion of Common Sense Reimbursement Provisions in Medicare Bill 21525 1Maine Community Pharmacy Owner Thanks Sen Snowe for Supporting Inclusion of Common Sense Reimbursement Provisions in Medicare Bill 21525 2Medco to Present at the William Blair 26 Company L L C 28th Annual Growth Conference 21522 1Medco to Present at the William Blair 26 Company L L C 28th Annual Growth Conference 21522 2SAIC to Webcast Presentation at William Blair Growth Stock Conference 21519 1SAIC to Webcast Presentation at William Blair Growth Stock Conference 21519 2Study of guanacos launched in Chile 3603 1Study of guanacos launched in Chile 3603 2
...-Jul 10, 2007 - Corgenix Medical,Corporation (OTC ...,reported new clinical data demonstrating a signif...any,s patented AtherOx(TM),bio-markers and cardiov...st Congress of the International Society on Thromb..., Data released this week shows the association of...
... 2007 /PRNewswire/ -- Portola,Pharmaceuticals, Inc...pound, PRT054021, an oral Factor Xa inhibitor, tod...y on Thrombosis and Haemostasis,(ISTH) in Geneva, ...1 was safe, effective, and well tolerated for the,...n patients,undergoing total knee replacement (TKR)...
Other Medicine Technology:Corgenix Reports New Clinical Data Correlating AtherOx Technology,With Vascular Disease 2Corgenix Reports New Clinical Data Correlating AtherOx Technology,With Vascular Disease 3Corgenix Reports New Clinical Data Correlating AtherOx Technology,With Vascular Disease 4Portola Pharmaceuticals Announces Positive Data from a Phase II,Study of its Factor Xa Inhibitor at the XXI Congress of the,International Society on Thrombosis and Haemostasis 2Portola Pharmaceuticals Announces Positive Data from a Phase II,Study of its Factor Xa Inhibitor at the XXI Congress of the,International Society on Thrombosis and Haemostasis 3Portola Pharmaceuticals Announces Positive Data from a Phase II,Study of its Factor Xa Inhibitor at the XXI Congress of the,International Society on Thrombosis and Haemostasis 4
... a national reference laboratory and a worldwide l...pment. ARUP offers an extensive test menu of highl... anatomic pathology. Owned by the University of Ut...alf of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide l...pment. ARUP offers an extensive test menu of highl... anatomic pathology. Owned by the University of Ut...alf of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide l...pment. ARUP offers an extensive test menu of highl... anatomic pathology. Owned by the University of Ut...alf of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide l...pment. ARUP offers an extensive test menu of highl... anatomic pathology. Owned by the University of Ut...alf of the nation's university teaching hospitals ...
Medicine Products: